Persistent swollen neck glands could be suspicious for cancer
the ONA take:
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations, according to two reports from University of Exeter Medical School, in the United Kingdom. Such referrals could save thousands of death each year from lymphoma.
Latest available figures from 1995 to 1999 show that more than 6,320 deaths were avoidable during that period. In addition, more than 40% of patients had visited their GP with symptoms three or more times before being referred for cancer investigations.
Both reports used data from UK primary care patient records from the Clinical Practice Research Datalink (CPRD), focusing on patients older than 40 years.
The two reports produced similar results. The researchers conclude that the risk that persistent swollen glands are indicative of cancer is higher than previously thought, and primary care providers should consider referring these patients to a specialist earlier.
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|